Importantly, we found that increased frequencies of the DP CD8 TILs correlate with a significantly reduced risk of death for patients with HPV-negative HNSCC, suggesting an important role for tumor antigen-specific CD8 TILs in limiting tumor growth in these patients. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.